Your browser doesn't support javascript.
loading
Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial.
Wang, Yamin; Xu, Qing; Jeyaseelan, Vishali; Ying, Zhifang; Mach, Ondrej; Sutter, Roland; Wen, Ning; Rodewald, Lance; Li, Changgui; Wang, Jie; Yuan, Hui; Yin, Zundong; Feng, Zijian; Xu, Aiqiang; An, Zhijie.
Afiliación
  • Wang Y; Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xu Q; Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • Jeyaseelan V; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
  • Ying Z; National Institutes for Food and Drug Control, Beijing, China.
  • Mach O; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
  • Sutter R; Polio Eradication Department, World Health Organization, Geneva, Switzerland.
  • Wen N; Chinese Center for Disease Control and Prevention, Beijing, China.
  • Rodewald L; Chinese Center for Disease Control and Prevention, Beijing, China.
  • Li C; National Institutes for Food and Drug Control, Beijing, China.
  • Wang J; Dezhou prefecture-level Center for Disease Control and Prevention, Dezhou, Shandong, China.
  • Yuan H; Liaocheng prefecture-level Center for Disease Control and Prevention, Liaocheng, Shandong, China.
  • Yin Z; Chinese Center for Disease Control and Prevention, Beijing, China.
  • Feng Z; Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xu A; Shandong Provincial Center for Disease Control and Prevention, Jinan, China.
  • An Z; Chinese Center for Disease Control and Prevention, Beijing, China.
Lancet Reg Health West Pac ; 10: 100133, 2021 May.
Article en En | MEDLINE | ID: mdl-34327346
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_medicamentos_vacinas_tecnologias / 2_cobertura_universal Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Reg Health West Pac Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_medicamentos_vacinas_tecnologias / 2_cobertura_universal Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Reg Health West Pac Año: 2021 Tipo del documento: Article País de afiliación: China